In this study, we aim to explore the role of BCAAs metabolism in NAFLD and the protective effect of BCATc Inhibitor 2 in oleic acid (OA)-induced formation of lipid droplet and apoptosis in hepatic cells. Here, BCAT1 is linked to metabolic dysfunction-associated steatotic liver disease.